New Filings & Updated Terms (ending 6.21.19am)

NEW FILINGS

Company: AMTD International Inc.
Symbol: TBD
Description: They are a leading Hong Kong-headquartered comprehensive financial institution.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): AMTD Global Markets, Tiger Global
Filed: 6-20-19
Listed Cash Raise: $200m

Company: Medallia, Inc.
Symbol: MDLA
Description: They created a new category of enterprise software, experience management, and they are the market leader.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Merrill Lynch, Citigroup, Wells Fargo Securities Credit Suisse
Co-Manager(s): Oppenheimer, William Blair, Needham, Craig Hallum Capital Group, Roth Capital
Filed: 6-21-19
Listed Cash Raise: $100m

Company: Phreesia, Inc.
Symbol: PHR
Description: They are a leading provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Wells Fargo Securities, William Blair, Allen & Co., Piper Jaffray
Filed: 6-21-19
Listed Cash Raise: $125m

Company: Fulcrum Therapeutics, Inc.
Symbol: FULC
Description: They are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, SVB Leerink
Filed: 6-21-19
Listed Cash Raise: $86.25m

Company: Mirum Pharmaceuticals, Inc.
Symbol: MIRM
Description: They are a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, Evercore ISI, Guggenheim Securities
Co-Manager(s): Raymond James, Roth Capital
Filed: 6-21-19
Listed Cash Raise: $86.25m

TERMS ADDED

Company: Karuna Therapeutics, Inc
Symbol: KRTX
Description: They are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.
Shares: 4.375 million
Price Range: $15.00-$17.00
Market Cap: $320m-$365m
Trade Date: Friday, 6/28
Underwriter(s): Goldman Sachs, Citigroup, Wells Fargo
Co-Manager(s): Wedbush PacGrow
Terms Added: 6-17-19

Company: BridgeBio Pharma, Inc.
Symbol: BBIO
Description: They are a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source.
Shares: 15 million
Price Range: $14.00-$16.00
Market Cap: $1.6bn-$1.85bn
Trade Date: Thursday, 6/27
Underwriter(s): J.P. Morgan, Goldman Sachs & Co, Jefferies, SVB Leerink, KKR
Co-Manager(s): Piper Jaffray, Mizuho Securities, BMO Capital Markets, Raymond James
Terms Added: 6-17-19

Company: Adaptive Biotechnologies Corporation
Symbol: ADPT
Description: They are advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
Shares: 12.5 million
Price Range: $15.00-$17.00
Market Cap: $1.8bn-$2.0bn
Trade Date: Thursday, 6/27
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): Cowen, Guggenheim, William Blair, BTIG
Terms Added: 6-17-19

Company: The RealReal, Inc.
Symbol: REAL
Description: The RealReal is the world’s largest online marketplace for authenticated, consigned luxury goods.
Shares: 15 million
Price Range: $17.00-$19.00
Market Cap: $1.4b-$1.57bn
Trade Date: Friday, 6/28
Underwriter(s): Credit Suisse, BofA Merrill Lynch, UBS Investment Bank
Co-Manager(s): KeyBanc Capital, Stifel, Cowen, Raymond James
Terms Added: 6-17-19

Company: Priam Properties Inc.
Symbol: PRMI
Description: They are a newly formed, self-administered and self-managed real estate investment company focused on acquiring, improving, owning and managing multi-tenant office properties in high-growth urban nodes in the Midwest and Southeast United States.
Shares: 9 million
Price Range: $18.00-$20.00
Market Cap: $160m-$180m
Trade Date: Thursday, 6/27
Underwriter(s): BofA Merrill Lynch, Baird, RBC Capital
Co-Manager(s): Stifel, BB&T Capital Markets, DA Davidson, Janney Montgomery Scott
Terms Added: 6-17-19